ArticleAnnals of the rheumatic diseases2022

Response to: 'High dosage of Methylprednisolone as a rescue, second-line treatment in COVID-19 patients who failed to respond to Tocilizumab' by Conticini

Sofia Ramiro et al.PubMed ↗Publisher ↗

No numbers read from the abstract.